Position in GHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$232,516,247
+$110,895,026 QoQ
Shares Held
8,650,158
0.0% QoQ
Ownership
12.6%
of shares outstanding
% of Portfolio
6.48%
of 13F equity value
Holder Rank
#2
of 62 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BVF INC/IL holds $3,440,293,274 across 41 Biotechnology names. GHRS ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,965,160 | $555,315,164 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
3,872,052 | $444,008,202 | |
| 3 | MLTX |
MoonLake Immunotherapeutics
|
16,001,284 | $311,544,999 | |
| 4 | GHRS |
GH Research PLC
This page
|
8,650,158 | $232,516,247 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
3,366,823 | $180,697,390 | |
| 6 | NKTR |
Nektar Therapeutics
|
2,391,075 | $166,920,945 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,056,027 | $123,629,080 | |
| 8 | XNCR |
Xencor Inc
|
7,133,720 | $114,852,892 |
All Filings in GHRS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $232,516,247 | 8,650,158 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $121,621,221 | 8,650,158 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $112,111,942 | 8,827,712 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $126,236,281 | 8,827,712 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $107,609,809 | 8,827,712 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $97,369,663 | 8,827,712 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $72,801,106 | 10,400,158 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $69,577,057 | 10,400,158 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $121,265,842 | 10,400,158 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $110,865,684 | 10,400,158 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $60,320,916 | 10,400,158 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $93,215,337 | 9,275,158 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $110,049,749 | 9,275,158 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $74,108,512 | 9,275,158 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $90,154,535 | 9,275,158 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $107,777,335 | 9,275,158 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $92,566,076 | 9,275,158 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $169,642,639 | 9,275,158 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $216,389,436 | 9,275,158 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $204,609,985 | 9,275,158 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $201,549,139 | 9,275,156 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||